Bee Venom Soluble Phospholipase A2 Exerts Neuroprotective Effects in a Lipopolysaccharide-Induced Mouse Model of Alzheimer’s Disease via Inhibition of Nuclear Factor-Kappa B-Reference-Cited by-同舟云学术

Bee Venom Soluble Phospholipase A2 Exerts Neuroprotective Effects in a Lipopolysaccharide-Induced Mouse Model of Alzheimer’s Disease via Inhibition of Nuclear Factor-Kappa B

Published:2019-11-01 Issue: Volume:11 Page:
ISSN:1663-4365
Container-title:Frontiers in Aging Neuroscience
language:
Short-container-title:Front. Aging Neurosci.

Author:

Ham Hyeon Joo,Han Ji Hye,Lee Yong Sun,Kim Ki Cheon,Yun Jaesuk,Kang Shin Kook,Park YangSu,Kim Se Hyun,Hong Jin Tae

Funder

National Research Foundation of Korea

Korea Institute for Advancement of Technology

Publisher

Frontiers Media SA

Subject

Cognitive Neuroscience,Ageing

Reference69 articles.

1. Osmotin attenuates LPS-induced neuroinflammation and memory impairments via the TLR4/NFκB signaling pathway;Badshah;Sci. Rep.,2016

2. Neuroprotective effects of CD4+CD25+Foxp3+ regulatory T cells in a 3xTg-AD Alzheimer’s disease model;Baek;Oncotarget,2016

3. Breaking immune tolerance by targeting Foxp3(+) regulatory T cells mitigates Alzheimer’s disease pathology;Baruch;Nat. Commun.,2015

4. Foxp3 interacts with nuclear factor of activated T cells and NF-κ B to repress cytokine gene expression and effector functions of T helper cells;Bettelli;Proc. Natl. Acad. Sci. U S A,2005

5. Letter: an anti-inflammatory peptide from bee venom;Billingham;Nature,1973

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bee venom as a promising therapeutic strategy in central nervous system diseases;Neuropeptides;2024-10

2. Can venoms be used in neuroprotection?;Natural Molecules in Neuroprotection and Neurotoxicity;2024

3. Knockdown and inhibition of hippocampal GPR17 attenuates lipopolysaccharide-induced cognitive impairment in mice;Journal of Neuroinflammation;2023-11-21

4. Differential roles of regulatory T cells in Alzheimer's disease;Cellular Immunology;2023-11

5. PLA2: Implications in neurological disorders as a prospective therapeutic target;Phospholipases in Physiology and Pathology;2023